nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Coordination disturbance—Hydrochlorothiazide—nephrolithiasis	0.185	0.224	CcSEcCtD
Nabilone—Panic disorder—Hydrochlorothiazide—nephrolithiasis	0.115	0.14	CcSEcCtD
Nabilone—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0288	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0177	0.1	CbGpPWpGaD
Nabilone—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0206	CcSEcCtD
Nabilone—Numbness—Hydrochlorothiazide—nephrolithiasis	0.016	0.0195	CcSEcCtD
Nabilone—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0186	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—CHRM3—nephrolithiasis	0.0145	0.0822	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0139	0.0788	CbGpPWpGaD
Nabilone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0164	CcSEcCtD
Nabilone—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0157	CcSEcCtD
Nabilone—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0135	CcSEcCtD
Nabilone—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.011	0.0134	CcSEcCtD
Nabilone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0129	CcSEcCtD
Nabilone—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0125	CcSEcCtD
Nabilone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0125	CcSEcCtD
Nabilone—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0124	CcSEcCtD
Nabilone—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0124	CcSEcCtD
Nabilone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0123	CcSEcCtD
Nabilone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00951	0.0115	CcSEcCtD
Nabilone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00932	0.0113	CcSEcCtD
Nabilone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00915	0.0111	CcSEcCtD
Nabilone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00908	0.011	CcSEcCtD
Nabilone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0107	CcSEcCtD
Nabilone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00855	0.0104	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00803	0.0455	CbGpPWpGaD
Nabilone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00771	0.00936	CcSEcCtD
Nabilone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00762	0.00925	CcSEcCtD
Nabilone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00852	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00688	0.039	CbGpPWpGaD
Nabilone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00665	0.00807	CcSEcCtD
Nabilone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00805	CcSEcCtD
Nabilone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00782	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0063	0.0357	CbGpPWpGaD
Nabilone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00756	CcSEcCtD
Nabilone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0062	0.00753	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00606	0.0344	CbGpPWpGaD
Nabilone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00725	CcSEcCtD
Nabilone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00693	CcSEcCtD
Nabilone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00686	CcSEcCtD
Nabilone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00683	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—RGS14—nephrolithiasis	0.0055	0.0312	CbGpPWpGaD
Nabilone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00665	CcSEcCtD
Nabilone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00545	0.00661	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0054	0.0306	CbGpPWpGaD
Nabilone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00655	CcSEcCtD
Nabilone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00538	0.00653	CcSEcCtD
Nabilone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00649	CcSEcCtD
Nabilone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00637	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00524	0.0297	CbGpPWpGaD
Nabilone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00634	CcSEcCtD
Nabilone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00633	CcSEcCtD
Nabilone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00632	CcSEcCtD
Nabilone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00624	CcSEcCtD
Nabilone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00621	CcSEcCtD
Nabilone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00616	CcSEcCtD
Nabilone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00601	CcSEcCtD
Nabilone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00601	CcSEcCtD
Nabilone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00601	CcSEcCtD
Nabilone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00599	CcSEcCtD
Nabilone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00594	CcSEcCtD
Nabilone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00588	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—PTH—nephrolithiasis	0.00479	0.0272	CbGpPWpGaD
Nabilone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00581	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00475	0.027	CbGpPWpGaD
Nabilone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00567	CcSEcCtD
Nabilone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00562	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00461	0.0262	CbGpPWpGaD
Nabilone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00557	CcSEcCtD
Nabilone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00549	CcSEcCtD
Nabilone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00538	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00525	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—RGS14—nephrolithiasis	0.00432	0.0245	CbGpPWpGaD
Nabilone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00521	CcSEcCtD
Nabilone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00517	CcSEcCtD
Nabilone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00514	CcSEcCtD
Nabilone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00512	CcSEcCtD
Nabilone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00507	CcSEcCtD
Nabilone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00501	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00411	0.0233	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00409	0.0232	CbGpPWpGaD
Nabilone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00497	CcSEcCtD
Nabilone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00493	CcSEcCtD
Nabilone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00493	CcSEcCtD
Nabilone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00475	CcSEcCtD
Nabilone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00471	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADCY10—nephrolithiasis	0.00382	0.0217	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTH—nephrolithiasis	0.00376	0.0213	CbGpPWpGaD
Nabilone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00455	CcSEcCtD
Nabilone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00455	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—DGKH—nephrolithiasis	0.00372	0.0211	CbGpPWpGaD
Nabilone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00425	CcSEcCtD
Nabilone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00413	CcSEcCtD
Nabilone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00408	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RGS14—nephrolithiasis	0.00325	0.0184	CbGpPWpGaD
Nabilone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00394	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00321	0.0182	CbGpPWpGaD
Nabilone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00381	CcSEcCtD
Nabilone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00366	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ADCY10—nephrolithiasis	0.003	0.017	CbGpPWpGaD
Nabilone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00363	CcSEcCtD
Nabilone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00363	CcSEcCtD
Nabilone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00361	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00296	0.0168	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—DGKH—nephrolithiasis	0.00292	0.0165	CbGpPWpGaD
Nabilone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00342	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PTH—nephrolithiasis	0.00271	0.0154	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00269	0.0152	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RGS14—nephrolithiasis	0.00255	0.0145	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTH—nephrolithiasis	0.00246	0.0139	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00232	0.0132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0022	0.0125	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DGKH—nephrolithiasis	0.0022	0.0125	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00212	0.012	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00211	0.012	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTH—nephrolithiasis	0.00193	0.0109	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00172	0.00978	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DGKH—nephrolithiasis	0.00172	0.00978	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CHRM3—nephrolithiasis	0.00159	0.00901	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTH—nephrolithiasis	0.00145	0.00824	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CHRM3—nephrolithiasis	0.00125	0.00707	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTH—nephrolithiasis	0.00114	0.00646	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—nephrolithiasis	0.000729	0.00414	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—nephrolithiasis	0.000572	0.00325	CbGpPWpGaD
